Paper
29 March 2000 Motexafin lutetium in graft coronary artery disease
Kathryn W. Woodburn, Shari L. Rodriquez, Atsushi Yamaguchi, Motoya Hayase, Robert C. Robbins, David Kessel
Author Affiliations +
Abstract
Graft coronary artery disease (GCAD) is the chief complication following cardiac transplantation. Presently, there are limited treatment options. Insights into more expedient diagnosis and amelioration, if only partially, of GCAD are fervently sought. The selectivity of Antrin Injection (Lu-Tex) with subsequent photoactivation has been evaluated in several preclinical atherosclerosis models. The inhibitory effect of Lu-Tex induced photosensitization was demonstrated with human bypass coronary smooth muscle cells. The biodistribution of Lu-Tex was evaluated in a rat model of heterotopic cardiac allografts 60 days following transplantation. Lu-Tex was retained in the cardiac allograft, exhibiting a five-fold increase in retention between the allograft and native heart. These findings lead us to suggest that further studies are warranted to ascertain the merits of Lu-Tex for the diagnosis and possible attenuation of chronic graft vascular disease.
© (2000) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Kathryn W. Woodburn, Shari L. Rodriquez, Atsushi Yamaguchi, Motoya Hayase, Robert C. Robbins, and David Kessel "Motexafin lutetium in graft coronary artery disease", Proc. SPIE 3909, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy IX, (29 March 2000); https://doi.org/10.1117/12.379878
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Heart

Arteries

Transplantation

Lutetium

Photodynamic therapy

Tissues

Luminescence

Back to Top